Biaxin Generic Clears FDA; Abbott Confident No Launch Before 2005
Executive Summary
Abbott expects Biaxin (clarithromycin) will remain free from generic competition until May 2005 despite the approval of the first ANDA for the antibiotic
You may also be interested in...
Ketek Launch Is First For Sanofi-Aventis; Merger Will Test Focus
Ketek will be the first product launch for the newly formed Sanofi-Aventis
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011